Thromboembolism after Astra Zeneca COVID-19 vaccine: Not always PF4- antibody mediated

References

• Wise J. Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots. BMJ. 2021 Mar 11;372:n699. doi:10.1136/bmj.n699. PMID: 33707182.
   PubMed Web of Science ®Google Scholar
• Fischer L. Spektrum der Wissenschaft. AstraZeneca-Impfstoff: Immunreaktion löst Thrombosen im Hirn aus. Heidelberg (Germany); 2021 Mar 19 [accessed 2021 May 1]. https://www.spektrum.de/news/astrazeneca-impfstoff-immunreaktion-loest-thrombosen-im-hirn-aus/1849132.
   Google Scholar
• Rico-Mesa JS, Rosas D, Ahmadian-Tehrani A, White A, Anderson AS, Chilton R. The role of anticoagulation in COVID-19-Induced hypercoagulability. Curr Cardiol Rep. 2020;22(7):53. doi:10.1007/s11886-020-01328-8. PMID: 32556892; PMCID: PMC7298694.
   PubMed Web of Science ®Google Scholar
• Edara VV, Lai L, Sahoo MK, Floyd K, Sibai M, Solis D, Flowers MW, Hussaini L, Ciric CR, Bechnack S, et al. Infection and vaccine-induced neutralizing antibody responses to the SARS-CoV-2 B.1.617.1 variant. J Virol. 2021;95(17):e0131321. doi:10.1128/JVI.01313-21. PMID: 34013272; PMCID: PMC8132229.
   PubMedGoogle Scholar
• Voysey M, Costa Clemens SA, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE, et al. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet. 2021;397(10277):881–7. doi:10.1016/S0140-6736(21)00432-3. Epub 2021 Feb 19. Erratum in: Lancet, 397(10277), 880. PMID: 33617777; PMCID: PMC7894131.
   PubMed Web of Science ®Google Scholar
• Ewer KJ, Barrett JR, Belij-Rammerstorfer S, Sharpe H, Makinson R, Morter R, Flaxman A, Wright D, Bellamy D, Bittaye M, et al. T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial. Nat Med. 2021;27(2):270–8. doi:10.1038/s41591-020-01194-5. Epub 2020 Dec 17. PMID: 33335323.
   PubMed Web of Science ®Google Scholar
• Mueller B. The U.K. reports more blood-clotting cases in people who received the AstraZeneca shot. New York Times. 2021 Apr 2 [accessed 2021 May 1]. https://www.nytimes.com/2021/04/02/world/uk-astrazeneca-blood-clots.html.
   Google Scholar
• Oldenburg J, Klamroth R, Langer F, Pötzsch B, Greinacher A. Gesellschaft für Thrombose- und Hämostaseforschung, Aktualisierte Stellungnahme der GTH nach dem Beschluss der EMA, die Impfungen mit dem AstraZeneca COVID-19 Vakzin fortzusetzen; Recommendations of the German Society of Thrombosis and Hemostasiology. Cologne (North Rhine Westphalia/Germany); 2021 Apr 1 [accessed 2021 May 1]. https://gth-online.org/wp-content/uploads/2021/04/GTH-Stellungnahme-AstraZeneca_4-1-2021.pdf.
   Google Scholar
• Paul-Ehrlich-Institut, Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel. Sicherheit von COVID-19 Impfstoffen. Langen (Hesse/Germany); 2021 Mar [accessed 2021 May 1]. https://www.pei.de/DE/newsroom/dossier/coronavirus/coronavirus-inhalt.html?cms_pos=5.
   Google Scholar
• Augart J. Inzidenz und Altersverteilung der Lungenembolie in Deutschland auf Basis der DRG-Statistik [ Doctoral thesis]. Germany: Department of Angiology, University of Duisburg-Essen; 2012.
   Google Scholar
• Joint Statement of the German. Austrian and Swiss societies of Gynecology: S3-Leitlinie Hormonelle Empfängnisverhütung; 2020 Jan 22 [accessed 2021 May 1]. https://www.awmf.org/uploads/tx_szleitlinien/015-015l_S3__Hormonelle_Empfaengnisverhuetung_2020-02.pdf.
   Google Scholar
• Beavis KG, Matushek S, Abeleda PF, Bethel C, Hunt C, Gillen S, Moran A, Tesic V. Evaluation of the EUROIMMUN anti-SARS-COV-2 ELISA Assay for detection of IgA and IgG antibodies. J Clin Virol. 2020;129:104468. Published online 2020 May 23. doi:10.1016/j.jcv.2020.104468.
   PubMed Web of Science ®Google Scholar
• Brodard J, Kremer Hovinga JA, Fontana P, Studt JD, Gruel Y, Greinacher A. COVID-19 patients often show high-titer non-platelet-activating anti-PF4/heparin IgG antibodies. J Thromb Haemost. 2021;19(5):1294–8. Published online ahead of print, Feb 7, 2021. doi:10.1111/jth.15262. PMID: 33550713.
   PubMed Web of Science ®Google Scholar
• Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. 2021 June 3;384(22):2092–101. doi:10.1056/NEJMoa2104840. Epub 2021 Apr 9. PMID: 33835769; PMCID: PMC8095372.
   PubMed Web of Science ®Google Scholar
• Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397(10269):99–111. doi:10.1016/S0140-6736(20)32661-1. Epub 2020 Dec 8. Erratum in: The Lancet, 397(10269), 98. PMID: 33306989; PMCID: PMC7723445.
   PubMed Web of Science ®Google Scholar
• Sukumar S, Lämmle B, Cataland SR. Thrombotic thrombocytopenic purpura: pathophysiology, diagnosis, and management. J Clin Med. 2021;10(3):536. doi:10.3390/jcm10030536. PMID: 33540569; PMCID: PMC7867179.
   PubMed Web of Science ®Google Scholar
• Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, Vanstapel A, Werlein C, Stark H, Tzankov A, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383(2):120–8. doi:10.1056/NEJMoa2015432. Epub 2020 May 21. PMID: 32437596; PMCID: PMC7412750.
   PubMed Web of Science ®Google Scholar
• Siddiqi HK, Libby P, Ridker PM. COVID-19 - a vascular disease. Trends Cardiovasc Med. 2021;31(1):1–5. doi:10.1016/j.tcm.2020.10.005.
   PubMed Web of Science ®Google Scholar
• Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203(2):631–7. doi:10.1002/path.1570. PMID: 15141377; PMCID: PMC7167720.
   PubMed Web of Science ®Google Scholar
• Cardot-Leccia N, Hubiche T, Dellamonica J, Burel-Vandenbos F, Passeron T. Pericyte alteration sheds light on micro-vasculopathy in COVID-19 infection. Intensive Care Med. 2020;46(9):1777–8. doi:10.1007/s00134-020-06147-7.
   PubMed Web of Science ®Google Scholar
• Abdel Rahman F, d’Almeida S, Zhang T, Asadi M, Bozoglu T, Bongiovanni D, von Scheidt M, Dietzel S, Schwedhelm E, Hinkel R, et al. Sphingosine-1-phosphate attenuates lipopolysaccharide-induced pericyte loss via activation of Rho-A and MRTF-A. Thromb Haemostasis. 2021;121(3):341–50. doi:10.1055/s-0040-1716844. Epub 2020 Oct 4. PMID: 33011963.
   PubMedGoogle Scholar
• Theuerkauf SA, Michels A, Riechert V, Maier TJ, Flory E, Cichutek K, Buchholz CJ. Quantitative assays reveal cell fusion at minimal levels of SARS-CoV-2 spike protein and fusion from without. iScience. 2021;24(3):102170. doi:10.1016/j.isci.2021.102170. Epub 2021 Feb 9. PMID: 33585805; PMCID: PMC7871100.
   PubMed Web of Science ®Google Scholar
• Vickers ER, McClure DL, Naleway AL, Jacobsen SJ, Klein NP, Glanz JM, Weintraub ES, Belongia EA. Risk of venous thromboembolism following influenza vaccination in adults aged 50 years and older in the vaccine Safety Datalink. Vaccine. 2017;35(43):5872–7. doi:10.1016/j.vaccine.2017.08.086. Epub 2017 Sep 6. PMID: 28888342; PMCID: PMC6508529.
   PubMed Web of Science ®Google Scholar
• Destefano F, Offit PA, Fisher A. Vaccine safety. In: Plotkin A Orenstein WA, editors. Plotkin’s vaccines; 2018. pp. 1584–600.e10. doi:10.1016/B978-0-323-35761-6.00082-1. Epub 2017 Jul 17. PMCID: PMC7173515.
   Google Scholar
• Keddie S, Pakpoor J, Mousele C, Pipis M, Machado PM, Foster M, Record CJ, Keh RYS, Fehmi J, Paterson RW, et al. Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome. Brain. 2020;144(2):682–93. doi:10.1093/brain/awaa433.
   Web of Science ®Google Scholar